Biogelx
Develops and supplies synthetic peptide hydrogels and bioinks for 3D bioprinting and cell culture, enabling in-vivo-like tissue models for drug discovery and regenerative medicine.
- CEO / Founder
- Alison Clayton
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $1M
- Latest Round
- Grant
- Key Investors
- Scottish Enterprise; Innovate UK; European Regional Development Fund
Technology & Products
Key Products
Biogelx™-S (standard hydrogel); Biogelx™-Inks (bioinks for 3D bioprinting); Peptide hydrogels for 3D cell culture
Technological Advantage
Proprietary peptide technology enables precise control over hydrogel properties (e.g., stiffness, porosity) to emulate various tissue types, validated in 3D bioprinting applications; advantage is defensible via trade secrets and potential patents.
Differentiation
Value Proposition
Provides reproducible, scalable, and tunable synthetic hydrogels that mimic native extracellular matrix, reducing reliance on animal-derived materials and improving predictive accuracy of in-vitro models for faster drug development.
How They Differentiate
Focuses on synthetic, peptide-based hydrogels (vs. animal-derived alternatives like Matrigel) with tunable mechanical properties for specific tissue modeling; offers bioinks compatible with extrusion bioprinting, emphasizing reproducibility and scalability for research applications.
Market & Competition
Target Customers
Academic researchers, pharmaceutical companies, biotechnology SMEs, tissue engineering labs
Industry Verticals
Pharmaceuticals; Biotechnology; Academic Research; Regenerative Medicine
Competitors
Cellink (BICO Group); VivoSim Labs (formerly Organovo); Advanced BioMatrix
Growth & Milestones
Growth Metrics
Supplied materials to over 100 research institutions globally; 300% revenue growth from 2019 to 2021; Expanded to US market in 2020
Major Milestones
2013: Won Royal Society of Chemistry’s Emerging Technologies competition, gaining GSK mentorship; 2016+: Global reputation in 2D/3D cell culture; peptide bioinks commercialized for bioprinting
Notable Customers
University of Glasgow; University of Strathclyde; AstraZeneca; GlaxoSmithKline